Filtronic PLC - New Contract Award
Filtronic plc has announced a new contract to develop advanced feeder link technology for Viasat and the European Space Agency's Direct-to-Device initiative. Part of the ESA ARTES 4.0 programme, this project aims to deliver 5G non-terrestrial services directly to handheld devices via a next-generation satellite network. Filtronic's high-power RF solutions will be key to this groundbreaking effort.
RUA Life Sciences - Trading Update
RUA Life Sciences reports 86% revenue growth to £4.1m with a strategic focus on contract manufacturing and IP exploitation. EBITDA is expected at £0.3m, a turnaround from a £1.6m loss. Cost control remains strong, and promising prospects in Medical Devices, Biomaterials, and Structural Heart are anticipated.
Brickability Group - Pre-Close Trading Update
Brickability Group PLC reports a strong FY25 performance with an expected revenue of £637 million, up 7% from FY24. Adjusted EBITDA is anticipated to surpass market expectations at £50 million. Despite challenging market conditions, the Group achieved a robust financial position and anticipates material growth as markets recover.
Greatland Gold PLC - Posting of Scheme Document
Greatland Gold plc is progressing toward a corporate reorganization for ASX listing. A court meeting on 12 May 2025 will consider approving a scheme of arrangement. If successful, Greatland Resources will become the new holding company. This move aims to enhance the company's capital markets profile and facilitate its growth strategy.
Mosman Oil & Gas - Company Update
Mosman Oil and Gas Limited (AIM: MSMN) announces key organizational updates, including the appointment of Graham Duncan as an independent Non-Executive Director and Tina Loh as Company Secretary. The company has also relocated its registered office to Sydney, Australia. Mosman continues its strategic focus on helium, hydrogen, and hydrocarbon projects in the US and Australia.
Chill Brands Group - Fundraising to raise £1m & Update on results
Chill Brands Group plc has announced an underwritten fundraising to raise £1 million and provided updates on the expected publication of its financial results. The proceeds will support product development and distribution efforts. Audit completion is anticipated by mid-May 2025, aiming to resume trading in the company's shares.
Shield Therapeutics - Audited results for the year ended 31 Dec 2024
Shield Therapeutics plc reported significant growth in 2024, with revenues reaching $32.3 million, primarily driven by a 153% increase in ACCRUFeR® sales to $29.3 million. The company secured $10 million in equity funding to support its goal of becoming cash flow positive by the end of 2025. Global expansion and development programs are progressing.
Fusion Antibodies - Approval of grant funding
Fusion Antibodies plc, in partnership with Queens University Belfast, announces the approval of a grant from InnovateUK Launchpad. The project, with £545k allocated to Fusion, aims to develop a humanised therapeutic DR5 antibody to address treatment-resistant cancers. This 18-month initiative will produce case studies to market Fusion's technologies.
Supermarket Inc REIT - Strategic Joint Venture with Blue Owl Capital
Supermarket Income REIT has entered a strategic joint venture with Blue Owl Capital, seeding it with £403 million of UK supermarkets. The JV aims to grow assets up to £1 billion. SUPR will reduce debt and reinvest proceeds while leveraging its management expertise and benefiting from ongoing management and performance fees.
Firering Strategic - Increases Interest in Zambian Quicklime Project
Firering Strategic Minerals plc announced an increase in its stake in Limeco Resources to 20.5% by acquiring an additional 3.8% for US$1,033,333. Limeco, located near Lusaka, Zambia, produces high-quality quicklime, essential for local copper mining. Firering retains an option to further increase its stake and aims to boost production amid rising demand.
Aviva PLC - Acquisition Financing Update
Aviva PLC has announced a recommended cash and share offer for Direct Line Insurance Group via a Scheme of Arrangement. The cash consideration for the acquisition will be funded from Aviva's existing resources, following the cancellation of the Bridge Facility Agreement with Goldman Sachs and Citi.
Afentra PLC - Final Results
Afentra PLC, focused on African oil and gas assets, reported strong 2024 performance with $180.9 million in revenue and a 5% production increase. Strategic growth included a 2024 Azule acquisition, increased water injection, and securing new Kwanza basin blocks. Afentra emphasizes sustainable development and plans further asset enhancement in 2025.
MicroSalt PLC - Q1 2025 Business Update
MicroSalt plc announces a record-breaking Q1 2025 with a 142% increase in bulk revenue compared to 2024. Bulk sales reached 98mT, powered by expansions in Great Britain and Belgium. The launch of MicroSalt Premium targets QSR/FSR markets, promising significant sales impact in 2025 and beyond. CEO Rick Guiney highlights the global growth of MicroSalt's low-sodium products.